Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.00
Bid: 137.50
Ask: 144.50
Change: 0.00 (0.00%)
Spread: 7.00 (5.091%)
Open: 141.00
High: 0.00
Low: 0.00
Prev. Close: 141.00
XAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scheduled Trading Statement

8 Jul 2019 07:00

RNS Number : 7147E
Xaar PLC
08 July 2019
 

Xaar plc

 

Scheduled Trading Statement

 

Xaar plc ("Xaar" or the "Group"), a world leader in industrial inkjet technology, provides its scheduled trading update for the six months ended 30 June 2019.

Trading is in line with the Board's expectations and Xaar expects to report revenue of approximately £23 million for the six months ended 30 June 2019. Overall revenue for the first half was £27 million however this was impacted by approximately £4 million of revenue reversal regarding Xaar 1201 inventory being returned to the business. We anticipate selling this inventory in the second half of the year. Cash at 30 June 2019 was £21.6 million.

Excluding one-time Royalties of approximately £10 million in H1 2018 and the prior years' revenue reversal of approximately £4 million in H1 2019, revenue grew by 8%.

Underlying trading in the Printhead business has stabilised after the declines of 2018 with growth in the Industrial and Packaging segments. Growth in Industrials came from Ceramics, Décor and Advanced Manufacturing, while in Packaging growth came from Coding and Marking. As referenced above, approximately £4 million revenue in the Graphics segment has been reversed due to Xaar 1201 inventory being returned for rework due to age. We have subsequently regained control of this inventory in order to drive payment recovery and explore broader channel options. Key new printhead products have shown good growth in the first half; Xaar 2001 (43%), Xaar 501 (88%) and in particular Xaar 5601 (490%) which continues to be very positively received by customers as recently witnessed at the ITMA textile printing show in Barcelona.

Our Product Print Systems business grew by 41% driven by growth in inkjet and pad printing equipment as well as consumables.

Xaar 3D Printing is on plan with strong positive customer feedback for our new printer and we continue to work closely with Stratasys on the next phase of our partnership.

Cash balances of £21.6 million at 30 June 2019 are in line with expectations, reflecting the improved working capital profile of the business. We continue to work diligently at improving our working capital and anticipate further progress through the second half of the year.

 

We have advanced on our strategic review of the Thin Film business and will provide an update on progress at the half year results due to be announced on 10 September 2019.

 

 

Enquiries:

Xaar plc

+44 (0)1223 423 663 

Doug Edwards, Chief Executive Officer

Shomit Kenkare, Chief Financial Officer

 

 

Tulchan Communications

+44 (0)20 7353 4200

James Macey White

David Ison

 

About XaarXaar is a world leader in the development of digital inkjet technology. Our technology drives the conversion of analogue printing and manufacturing methods to digital inkjet which is more efficient, more economical and more productive than the traditional methods which have been in use for years. We design and manufacture printheads as well as systems for product decoration and industrial 3D Printing which use our inkjet technology. We are the only truly independent inkjet technology company with over 25 years of know how. We offer unrivalled inkjet expertise including technology and printhead design and development, and manufacture highly customised product decoration systems and industrial 3D Printing for volume manufacturing. Our unique technologies and products are the leading enabler for innovation and for driving supply chain efficiencies for many industries. Information about Xaar is at www.xaar.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKDLFBKDFLBBB
Date   Source Headline
21st Oct 20089:00 amRNSHolding(s) in Company
15th Oct 20087:00 amRNSInterim Management Statement
13th Oct 20084:41 pmRNSSecond Price Monitoring Extn
13th Oct 20084:36 pmRNSPrice Monitoring Extension
30th Sep 20087:00 amRNSNotice of IMS
5th Sep 200810:00 amRNSBlocklisting Interim Review -
5th Sep 20089:08 amRNSBlocklisting Interim Review
4th Sep 20089:00 amRNSHolding(s) in Company
3rd Sep 20084:14 pmRNSDirector/PDMR Shareholding
28th Aug 200810:27 amRNSDirector/PDMR Shareholding
20th Aug 20087:00 amRNSHalf Yearly Report and Result
6th Aug 20087:00 amRNSNotice of Half Year Report
29th Jul 20089:39 amRNSHolding(s) in Company
25th Jul 20081:46 pmRNSHolding(s) in Company
15th Jul 200810:46 amRNSHolding(s) in Company
11th Jul 20087:00 amRNSPeriod end update & new broke
5th Jun 20086:00 pmRNSTotal Voting Rights
30th May 20087:00 amRNSAnalyst/investor visit to Dru
23rd May 20087:00 amRNSChina business update: recent
15th May 20082:49 pmRNSHolding(s) in Company
14th May 200810:10 amRNSDirectorate Change
13th May 200812:04 pmRNSResult of AGM
13th May 200812:04 pmRNSResult of AGM
13th May 20086:00 amRNSInterim Management & AGM Stat
9th May 200811:48 amRNSTotal Voting Rights
29th Apr 20082:23 pmRNSDirector/PDMR Shareholding
28th Apr 20084:35 pmRNSHolding(s) in Company
28th Apr 20087:00 amRNSDrupa exhibition preview
10th Apr 20083:50 pmRNSAnnual Information Update
2nd Apr 20085:43 pmRNSTotal Voting Rights
27th Mar 20086:27 pmRNSHolding(s) in Company
13th Mar 200810:21 amRNSDividend Payment Date
13th Mar 20087:01 amRNSFinal Results
19th Feb 20087:00 amRNSNotice of Final Results
8th Feb 20087:00 amRNSCustomer product launch
30th Jan 20087:00 amRNSDirectorate Change
29th Jan 20087:01 amRNSControl change for partner
10th Jan 20087:01 amRNSYear end trading update
9th Jan 20087:00 amRNSHolding(s) in Company
4th Jan 20083:59 pmRNSTotal Voting Rights
2nd Jan 20089:53 amRNSHolding(s) in Company
11th Dec 200712:25 pmRNSHolding(s) in Company
6th Dec 20075:17 pmRNSTotal Voting Rights
30th Nov 200710:26 amRNSHolding(s) in Company
30th Nov 20077:00 amRNSHolding(s) in Company
27th Nov 200710:12 amRNSHolding(s) in Company
31st Oct 20078:30 amRNSHolding(s) in Company
17th Oct 20076:36 pmRNSHolding(s) in Company
15th Oct 20077:00 amRNSAppointment of Director
5th Oct 20075:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.